ReWalk Robotics Ltd (RWLK)

[abira]

Alinea101's comments on Seeking Alpha nicely summarizes the current issues with the Rewalk company.

The issues with Rewalk:
1) The fight for reimbursement is expensive (case by case is not sustainable)
2) Cash burn is high $5,500,000 each quarter to sell only 20 rewalk systems
3) Rewalk spends $5.5M to generate $1.6M in revenue each quarter (NOT GOOD at all)
4) No growth YoY
5) New product 15-21 months away & NOT FDA approved
6) Increasing Authorized Share Count by $56,000,000
7) Timwell $20,000,000 Investment CANCELED
8) No large institutions buying & no insider buying
9) CEO should step down or retire (stock price since IPO $25 to $0.68 under Larry Jasinski)
10) Sales are forecasted to decline in the next 2-3 quarters by analysts
11) Rewalk Robotics also received a notice of DELISTING last week. If past stock behavior is indicative of future behavior, RWLK very well may get delisted to OTC.

Q3 2018 cash burn was less than $5.5 million and I don't think they are expecting a decline in sales in the next 2-3 quarters but the rest are valid points.